DNA Q2 2022 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena

DNAGinkgo Bioworks Holdings, Inc.

$418M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$145M+231.4% YoY

Gross Profit

$81M55.8% margin

Operating Income

-$648M-447.9% margin

Net Income

-$669M-462.5% margin

EPS (Diluted)

$-16.51

QoQ Revenue Growth

-14.1%

Cash Flow

Operating Cash Flow

-$99M

Free Cash Flow

-$109M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$427M

Stockholders' Equity

$1.5B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$145M	$44M	+231.4%
Gross Profit	$81M	$27M	+204.3%
Operating Income	-$648M	-$60M	-980.6%
Net Income	-$669M	-$54M	-1139.9%

Revenue Segments

Service

$96M67%

Foundry Revenue

$44M31%

Product

$4M3%